Measles virus nucleocapsid protein binds to Fcγ/RII and inhibits human B cell antibody production

Journal of Experimental Medicine

Volumn 186, Issue 2, 1997, Pages 269-278

  Ravanel, Kissia ^a   Castelle, Claire ^b   Defrance, Thierry ^c   Wild, T Fabian ^c   Charron, Dominique ^b   Lotteau, Vincent ^d   Rabourdin Combe, Chantal ^a,e  

^a Univ Claude Bernard   (France)

^b CENTRE DE RECHERCHE DES CORDELIERS   (France)

^c INSTITUT PASTEUR   (France)

^d U391   (France)

^e UNIVERSITÉ DE LYON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR; VIRUS PROTEIN;

ANIMAL CELL; ANTIBODY PRODUCTION; ARTICLE; HUMAN; HUMAN CELL; MEASLES VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RECEPTOR BINDING; VIRUS NUCLEOCAPSID;

ANIMALS; ANTIBODY FORMATION; B-LYMPHOCYTES; CELLS, CULTURED; HUMANS; IMMUNE TOLERANCE; MEASLES; MICE; NUCLEOPROTEINS; RECEPTORS, ANTIGEN, B-CELL; RECEPTORS, IGG; VIRAL PROTEINS;

EID: 0030743959     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.186.2.269     Document Type: Article

References (51)

1. Naniche, D., G. Varior-Krishnan, F. Cervoni, T.F. Wild, B. Rossi, C. Rabourdin-Combe, and D. Gerlier. 1993. Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. J. Virol. 67:6025-6032.
2. Dorig, R.E., A. Marcil, A. Chopra, and C.D. Richardson. 1993. The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell. 75:295-305.
3. Graves, M., D.E. Griffin, R.T. Johnson, R.L. Hirsch, I.L. de Soriano, S. Roedenbeck, and A. Vaisberg. 1984. Development of antibody to measles virus polypeptides during complicated and uncomplicated measles virus infections. J. Virol. 49:409-412.
4. Norrby, E., and Y. Gollmar. 1972. Appearance and persistence of antibodies against different virus components after regular measles infections. Infect. Immun. 6:240-247.
5. 8+ cytotoxic T cell clones. J. Immunol. 142:2847-2854.
6. Ilonen, J., M.J. Makela, B. Ziola, and A.A. Salmi. 1990. Cloning of human T cells specific for measles virus haemagglutinin and nucleocapsid. Clin. Exp. Immunol. 81:212-217.
7. Jacobson, S., R.P. Sekaly, C.L. Jacobson, H.F. McFarland, and E.O. Long. 1989. HLA class II-restricted presentation of cytoplasmic measles virus antigens to cytotoxic T cells. J. Virol. 63:1756-1762.
8. Bankamp, B., U.G. Brinckmann, A. Reich, S. Niewiesk, V. ter Meulen, and U.G. Liebert. 1991. Measles virus nucleocapsid protein protects rats from encephalitis. J. Virol. 65: 1695-1700.
9. Lanzavecchia, A. 1985. Antigen-specific interaction between T and B cells. Nature (Lond.). 314:537-539.
10. Amigorena, S., C. Bonnerot, J.R. Drake, D. Choquet, W. Hunziker, J.G. Guillet, P. Webster, C. Sautes, I. Mellman, and W.H. Fridman. 1992. Cytoplasmic domain heterogeneity and functions of IgG Fc receptors in B lymphocytes. Science (Wash. DC). 256:1808-1812.
11. Esposito-Farese, M.E., C. Sautes, H. de la Salle, S. Latour, T. Bieber, C. de la Salle, P. Ohlmann, W.H. Fridman, J.P. Cazenave, J.L. Teillaud, et al., 1995. Membrane and soluble Fcγ RII/III modulate the antigen-presenting capacity of murine dendritic epidermal Langerhans cells for IgG-complexed antigens. J. Immunol. 155:1725-1736.
12. Von Pirquet, C. 1908. Das verhalten der kutanen tuberkulin-reaktion wahrend der masern. Dtsch. Med. Wochenschr. 34: 1297-1300.
13. Hirsch, R.L., D.E. Griffin, R.T. Johnson, S.J. Cooper, I.L. de Soriano, S. Roedenbeck, and A. Vaisberg. 1984. Cellular immune responses during complicated and uncomplicated measles virus infections of man. Clin. Immunol. Immunopathol. 31:1-12.
14. Griffin, D.E., B.J. Ward, and L.M. Esolen. 1994. Pathogenesis of measles virus infection: an hypothesis for altered immune responses. J. Infect. Dis. 170:S24-S31.
15. Whittle, H.C., A. Bradley-Moore, A. Fleming, and B.M. Greenwood. 1973. Effects of measles on the immune response of Nigerian children. Arch. Dis. Child. 48:753-756.
16. Coovadia, H.M., M.A. Parent, W.E. Loening, A. Wesley, B. Burgess, F. Hallett, P. Brain, J. Grace, J. Naidoo, P.M. Smythe, and G.H. Vos. 1974. An evaluation of factors associated with the depression of immunity in malnutrition and in measles. Am. J. Clin. Nutr. 27:665-669.
17. Tishon, A., M. Manchester, F. Scheiflinger, and M.B. Oldstone. 1996. A model of measles virus-induced immunosuppression: enhanced susceptibility of neonatal human PBLs. Nat. Med. 2:1250-1254.
18. Norrby, E., G. Enders-Ruckle, and V. Meulen. 1975. Differences in the appearance of antibodies to structural components of measles virus after immunization with inactivated and live virus. J. Infect. Dis. 132:262-269.
19. Hussey, G.D., E.A. Goddard, J. Hughes, J.J. Ryon, M. Kerran, E. Carelse, P.M. Strebel, L.E. Markowitz, J. Moodie, P. Barron, et al. 1996. The effect of Edmonston-Zagreb and Schwarz measles vaccines on immune response in infants. J. Inject. Dis. 173:1320-1326.
20. Auwaerter, P.G., G.D. Hussey, E.A. Goddard, J. Hughes, J.J. Ryon, P.M. Strebel, D. Beatty, and D.E. Griffin. 1996. Changes within T cell receptor Vβ subsets in infants following measles vaccination. Clin. Immunol. Immunopathol. 79:163-170.
21. Lafon, M., M. Lafage, A. Martinez-Arends, R. Ramirez, F. Vuillier, D. Charron, V. Lotteau, and D. Scott-Algara. 1992. Evidence for a viral superantigen in humans. Nature (Lond.). 358:507-510.
22. Ono, S.J., V. Bazil, M. Sugawara, and J.L. Strominger. 1991. An isotype-specific trans-acting factor is defective in a mutant B cell line that expresses HLA-DQ, but not -DR or -DP. J. Exp. Med. 173:629-637.
23. Calman, A.F., and B.M. Peterlin. 1987. Mutant human B cell lines deficient in class II major histocompatibility complex transcription. J. Immunol. 139:2489-2495.
24. Accolla, R.S. 1983. Human B cell variants immunoselected against a single Ia antigen subset have lost expression of several Ia antigen subsets. J. Exp. Med. 157:1053-1058.
25. Van Den Herik-Oudijk, I.E., N.A. Westerdaal, N.V. Henriquez, P.J. Capel, and J.G. Van De Winkel. 1994. Functional analysis of human FcγRII (CD32) isoforms expressed in B lymphocytes. J. Immunol. 152:574-585.
26. Giraudon, P., and T.F. Wild. 1981. Monoclonal antibodies against measles virus. J. Gen. Virol. 54:325-332.
27. Unkeless, J.C. 1979. Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors. J. Exp. Med. 150:580-596.
28. Pulford, K., E. Raltkiaer, S.M. MacDonald, W.N. Erber, B. Falini, K.C. Gatter, and D.Y. Mason. 1986. A new monoclonal antibody (KB61) recognizing a novel antigen which is selectively expressed on a subpopulation of human B lymphocytes. Immunology. 57:71-76.
29. Buckland, R., C. Gerald, D. Barker, and F. Wild. 1988. Cloning and sequencing of the nucleoprotein gene of measles virus (Hallé strain). Nucleic Acids Res. 16:11821.
30. Udem, S.A., and K.A. Cook. 1984. Isolation and characterization of measles virus intracellular nucleocapsid RNA. J. Virol. 49:57-65.
31. Defrance, T., P. Carayon, G. Billian, J.C. Guillemot, A. Minty, D. Caput, and P. Ferrara. 1994. Interleukin 13 is a B cell stimulating factor. J. Exp. Med. 179:135-143.
32. Birrer, M.J., B.R. Bloom, and S. Udem. 1981. Characterization of measles polypeptides by monoclonal antibodies. Virology. 108:381-390.
33. Lund, G.A., D.L. Tyrrell, R.D. Bradley, and D.G. Scraba. 1984. The molecular length of measles virus RNA and the structural organization of measles nucleocapsids. J. Gen. Virol. 65:1535-1542.
34. Chan, P.L., and N.R. Sinclair. 1971. Regulation of the immune response. V. An analysis of the function of the Fc portion of antibody in suppression of an immune response with respect to interaction with components of the lymphoid system. Immunology. 21:967-981.
35. Silvy, A., C. Lagresle, C. Bella, and T. Defrance. 1996. The differentiation of human memory B cells into specific antibody-secreting cells is CD40 independent. Eur. J. Immunol. 26:517-524.
36. Fooks, A.R., J.R. Stephenson, A. Warnes, A.B. Dowsett, B.K. Rima, and G.W. Wilkinson. 1993. Measles virus nucleocapsid protein expressed in insect cells assembles into nucleocapsid-like structures. J. Gen. Virol. 74:1439-1444.
37. Spehner, D., A. Kirn, and R. Drillien. 1991. Assembly of nucleocapsidlike structures in animal cells infected with a vaccinia virus recombinant encoding the measles virus nucleoprotein. J. Virol. 65:6296-6300.
38. Cambier, J.C. 1995. Antigen and Fc receptor signaling. The awesome power of the immunoreceptor tyrosine-based activation motif (ITAM). J. Immunol. 155:3281-3285.
39. Bankamp, B., S.M. Horikami, P.D. Thompson, M. Huber, M. Billeter, and S.A. Moyer. 1996. Domains of the measles virus N protein required for binding to P protein and sell-assembly. Virology. 216:272-277.
40. Buckland, R., P. Giraudon, and F. Wild. 1989. Expression of measles virus nucleoprotein in Escherichia coli: use of deletion mutants to locate the antigenic sites. J. Gen. Virol. 70:435-441.
41. Rima, B.K., J.A. Earle, R.P. Yeo, L. Herlihy, K. Baczko, V. ter Meulen, J. Carabana, M. Caballero, M.L. Celma, and R. Fernandez-Munoz. 1995. Temporal and geographical distribution of measles virus genotypes. J. Gen. Virol. 76:1173-1180.
42. Scharenberg, A.M., and J.P. Kinet. 1996. The emerging field of receptor-mediated inhibitory signaling: SHP or SHIP? Cell. 87:961-964.
43. Uher, F., M.C. Lamers, and H.B. Dickler. 1985. Antigen-antibody complexes bound to B-lymphocyte fcγ receptors regulate B-lymphocyte differentiation. Cell. Immunol. 95:368-379.
44. Uher, F., and H.B. Dickler. 1986. Cooperativity between B lymphocyte membrane molecules: independent ligand occupancy and cross-linking of antigen receptors and Fcγ receptors down-regulates B lymphocyte function. J. Immunol. 137: 3124-3129.
45. Casali, P., G.P. Rice, and M.B. Oldstone. 1984. Viruses disrupt functions of human lymphocytes. Effects of measles virus and influenza virus on lymphocyte-mediated killing and antibody production. J. Exp. Med. 159:1322-1337.
46. McChesney, M.B., R.S. Fujinami, P.W. Lampert, and M.B. Oldstone. 1986. Viruses disrupt functions of human lymphocytes. II. Measles virus suppresses antibody production by acting on B lymphocytes. J. Exp. Med. 163:1331-1336.
47. McChesney, M.B., J.H. Kehrl, A. Valsamakis, A.S. Fauci, and M.B. Oldstone. 1987. Measles virus infection of B lymphocytes permits cellular activation but blocks progression through the cell cycle J. Virol. 61:3441-3447.
48. Schlender, J., J.J. Schnorr, P. Spielhoffer, T. Cathomen, R. Cattaneo, M.A. Billeter, V. ter Meulen, and S. Schneider-Schaulies. 1996. Interaction of measles virus glycoproteins with the surface of uninfected peripheral blood lymphocytes induces immunosuppression in vitro. Proc. Natl. Acad. Sci. USA. 93:13194-13199.
49. Griffin, D.E. 1995. Immune responses during measles virus infection. Curr. Top. Microbiol. Immunol. 191:117-134.
50. Karp, C.L., M. Wysocka, L.M. Wahl, J.M. Ahearn, P.J. Cuomo, B. Sherry, G. Trinchieri, and D.E. Griffin. 1996. Mechanism of suppression of cell-mediated immunity by measles virus. Science (Wash. DC). 273:228-231.
51. Cooper, J.A., Jr., R. Carcelen, and R. Culbreth. 1996. Effects of influenza A nucleoprotein on polymorphonuclear neutrophil function. J. Infect. Dis. 173:279-284.